TABLE OF CONTENTS As filed with the Securities and Exchange Commission confidentially on October 20, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) 2834 (Primary Standard Industrial Classification Code Number) 87-3198325 (I.R.S. Employer 2614 Boston Post Road, Suite 33AR Guilford, Connecticut 06437 (203 ...